MET amplification + MET Exon 14 mutation

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	MET amplification + MET Exon 14 mutation	Non Small Cell Lung Cancer	crizotinib Sensitive: C2 – Inclusion Criteria crizotinib Sensitive : C2	crizotinib Sensitive: C2 – Inclusion Criteria crizotinib Sensitive : C2
MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma	MET amplification + MET Exon 14 mutation	Lung Adenocarcinoma	savolitinib Sensitive: C4 – Case Studies savolitinib Sensitive : C4	savolitinib Sensitive: C4 – Case Studies savolitinib Sensitive : C4

Associations